| Page 42 | Rogel Cancer Center | University of Michigan

Perspectives with Max Wicha Max Wicha, M.D., founding director of the Rogel Cancer Center, reflects on the progress of cancer treatment and research on the 50th anniversary of the National Cancer Act. From his perspective, this act changed the way doctors treated cancer and encouraged them to share information with researchers. By combining their efforts, better and more effective treatments were developed. Read more about Perspectives with Max Wicha	Arul Chinnaiyan awarded prestigious Sjoberg Prize for cancer research Arul M. Chinnaiyan, M.D., Ph.D., was awarded the 2022 Sjöberg Prize by the Royal Swedish Academy of Sciences, which also awards Nobel Prizes. Chinnaiyan is being honored for the discovery of recurrent gene fusions in prostate cancer, a groundbreaking finding initially published in 2005 that has led to a better understanding of how prostate cancer develops and improved methods to detect the disease. Read more about Arul Chinnaiyan awarded prestigious Sjoberg Prize for cancer research	Evan Keller to serve as inaugural OVPC Director of Research Cores Evan Keller, D.V.M., Ph.D., associate director of shared resources at the Rogel Cancer Center, has been appointed to a new directorship in the University of Michigan’s Office of the Vice President for Research, according to Vice President for Research Rebecca Cunningham, M.D. Read more about Evan Keller to serve as inaugural OVPC Director of Research Cores	Emphasizing Equity Combating cancer disparities has been a longtime priority for Rogel Cancer Center, well before events like the Black Lives Matter movement and the COVID-19 pandemic broadened the public consciousness of society’s systemic inequities. But recently, Rogel created a new position: an associate director for diversity, equity, inclusion and justice. Equity work requires constant commitment, which leads to a level of consistency, in terms of approaches to patient care, research, teaching and community outreach. Read on to learn more. Read more about Emphasizing Equity
Found in Translation As Eric Fearon, M.D., Ph.D., Rogel Cancer Center Director has said; "Basic science research is one of our most important missions — and our members are investigating important areas including the functions of the tumor microenvironment, key signaling changes in cancer cells and tumor stroma, and epigenetic mechanisms of cancer development. Yet its equally important for us to continue to seek opportunities to translate this new knowledge into effective strategies for prevention, early diagnosis and treatment. Read on to learn more about this aspect of research at Rogel. Read more about Found in Translation	The Cancer Microbiome Scientists are just starting to appreciate the many ways microbes influence the initiation, progression and treatment of cancer. It's known that some microbiomes, like Helicobacter pylori’s triggers chronic inflammation that contributes to stomach cancer. It's also known that maintaining a a healthy gut microbiome nurtures our immune system so that our immune cells can fight against cancer. Learn how the Rogel Cancer Center research members are studying these microbiomes to better understand how to prevent and treat the development of gastrointestinal cancers. Read more about The Cancer Microbiome	New physics-based computation and AI framework at U-M explores aggressive behavior of cancer cells A team of interdisciplinary researchers at the University of Michigan, backed by a $1 million W.M. Keck Foundation grant, has developed a high-risk, high-reward approach to understand how each cell in a population processes information and translates that to action driving cancer cell progression. Read more about New physics-based computation and AI framework at U-M explores aggressive behavior of cancer cells	7 U-M Rogel Cancer Center researchers named AAAS fellows for 2021 The University of Michigan Rogel Cancer Center is home to seven members selected as 2021 fellows of the American Association for the Advancement of Science. These Rogel Cancer Center researchers are among 564 scientists, engineers and innovators spanning 24 scientific disciplines, recognized for their scientifically and socially distinguished achievements. Read more about 7 U-M Rogel Cancer Center researchers named AAAS fellows for 2021
Susan Clare Pitt MD Read more about Susan Clare Pitt MD	Find Us On Social Media For the most up-to-date news and information about cancer treatment and research at the Rogel Cancer Center visit our social media accounts and follow us!/ Read more about Find Us On Social Media

For the most up-to-date news and information about cancer treatment and research at the Rogel Cancer Center visit our social media accounts and follow us!/

Pages